NDC 55111-221-79 - Lamotrigine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55111-221
- Requested NDC
- 55111-221-79
- Package NDCs from labels
- 55111-221-30, 55111-221-60, 55111-221-01, 55111-221-05, 55111-221-79, 55111-221-78
- Manufacturer
- Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited FTO-3
- Effective date
- 2024-12-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lamotrigine - Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited FTO-3 | Dr.Reddy's Laboratories Limited | Dr.Reddy's Laboratories Limited FTO-3 | 2024-12-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55111-221-01 | Lamotrigine | 100 in 1 BOTTLE | TABLET | 100 | 11 | |
| 55111-221-05 | Lamotrigine | 500 in 1 BOTTLE | TABLET | 500 | 11 | |
| 55111-221-30 | Lamotrigine | 30 in 1 BOTTLE | TABLET | 30 | 11 | |
| 55111-221-60 | Lamotrigine | 60 in 1 BOTTLE | TABLET | 60 | 11 | |
| 55111-221-78 | Lamotrigine | 10 in 1 CARTON | TABLET | 10 | 11 | |
| 55111-221-79 | Lamotrigine | 10 in 1 BLISTER PACK | TABLET | 10 | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55111-221-01 | EA - Each | 55111-221 | a62522b4-7c51-4592-9529-3e11ad0420f8 | 1 | 2012-07-24 |
| 55111-221-05 | EA - Each | 55111-221 | f0476f37-8011-483e-891a-fee540fe3263 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LAMOTRIGINE | ACTIVE INGREDIENT | U3H27498KS | LAMOTRIGINE TABLET [DR.REDDY'S LABORATORIES LIMITED] | 9 | |
| Lamotrigine | ACTIVE MOIETY | U3H27498KS | LAMOTRIGINE TABLET [DR.REDDY'S LABORATORIES LIMITED] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LAMOTRIGINE Kit | LAMOTRIGINE | OWP Pharmaceuticals, Inc. | 474fb321-575c-4b97-9dbe-080061652ee4 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 282401 198427 U3H27498KS |
| SUBVENITE | LAMOTRIGINE | OWP Pharmaceuticals, Inc. | 7ad18b68-ba16-4810-9c3e-27fa970454e8 | 2026-03-27 | Boxed warning, Warnings, Adverse reactions | 282401 198428 198427 198429 U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Alembic Pharmaceuticals Limited | 03610cdf-7eaa-445c-a441-ff17be5a7c68 | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Rising Pharma Holdings, Inc. | f54690b3-bcbb-4d94-95b9-b7591af00117 | 2026-03-26 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | REMEDYREPACK INC. | 260dc37d-6e64-4688-82dc-10a1a428af17 | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Aurobindo Pharma Limited | e08920c2-04a3-4fb5-acc5-0af3140f82e9 | 2026-03-18 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Torrent Pharmaceuticals Limited | 52df02a7-83da-4b20-9951-69790237dc24 | 2026-03-04 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Alembic Pharmaceuticals Inc. | df34faa4-829e-413a-a230-cbec604eead9 | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | American Health Packaging | 6034a8b8-9e80-43ca-b84f-ea82f788268c | 2026-03-02 | Boxed warning, Warnings, Adverse reactions | 198428 198429 U3H27498KS |
| lamotrigine | LAMOTRIGINE | Alembic Pharmaceuticals Inc. | 05cba628-b12c-44d8-89a8-3522fe417cc1 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Alembic Pharmaceuticals Inc. | 4bd7193f-a81a-4909-90c2-7f324fc6ddfd | 2026-02-23 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| lamotrigine | LAMOTRIGINE EXTENDED-RELEASE | Camber Pharmaceuticals Inc | e45bd69f-3580-ff15-e053-2a95a90a4615 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Glenmark Pharmaceuticals Inc., USA | 50fcf452-2d21-493e-a1dd-0c6ea9ac6184 | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine Extended-Release | LAMOTRIGINE | Par Health USA, LLC | d5ec4d58-c669-4ab4-ba62-b71007536854 | 2026-01-21 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Preferred Pharmaceuticals Inc. | 634dbe6c-4874-4d54-aa25-be02d3341f16 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | 198427 U3H27498KS |
| Lamotrigine | LAMOTRIGINE | AvKARE | a63e19c0-a093-e896-e053-2a95a90a7ccd | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | U3H27498KS |
| Lamotrigine | LAMOTRIGINE | NuCare Pharmaceuticals, Inc. | 47fd2592-2fc6-9787-e063-6394a90a8f01 | 2026-01-09 | Boxed warning, Warnings, Adverse reactions | 198427 U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Quallent Pharmaceuticals Health LLC | 7977c87f-b459-486a-9edc-0a2071c46f4c | 2026-01-03 | Boxed warning, Warnings, Adverse reactions | 282401 198428 198427 198429 U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Northwind Health Company, LLC | 03fd8413-df56-50ab-e063-6394a90a6950 | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 198427 U3H27498KS |
| Lamotrigine | LAMOTRIGINE | Northwind Health Company, LLC | db5f7ee5-9bd9-1819-e053-2a95a90a91df | 2026-01-01 | Boxed warning, Warnings, Adverse reactions | 282401 U3H27498KS |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.